CVD Develops Advanced Fluid Reactors
CENTRAL ISLIP, N.Y., (Business Wire) – November 26, 2018 - CVD Equipment Corporation (NASDAQ: CVV), a leading provider of chemical vapor deposition systems has developed a family of advanced Fluid Reactors based on its innovations in nanotechnology and chemical vapor deposition technology. The Fluid Reactor is enabled by a novel reactor core element which allows the efficient transfer of gases into and out of liquids. The market adoption of this technology could supplant existing hollow fiber membrane technology for applications including filtration and liquid gasification or degasification. One such application is blood oxygenation cartridges, known as Extra Corporeal Membrane Oxygenators, which are typically used during cardio pulmonary bypass (CPB) surgery and are essential for life support. CVD has a patent pending embodying this technology.
CVD’s advanced Fluid Reactor incorporates an open-pore cellular network nanotechnology material having a strong bi-continuous phase structure. Two key steps in the material manufacturing are Chemical Vapor Deposition (CVD) growth of Carbon Nanotubes (CNTs) followed by a Chemical Vapor Infiltration (CVI) process. “We are very excited for the potential applications of this nanotechnology material developed in our Applications Laboratory and we feel this material system has significant market potential,” said Leonard Rosenbaum, President and Chief Executive Officer.
Mr. Rosenbaum further stated that, “Nanotechnology allows us to achieve fluid reactors having greater than a 10x active surface area to reactor core volume ratio as compared to fluid reactors based on traditional hollow fiber membranes. When optimally packaged, this translates into a higher productivity rate for a targeted fluid reaction per given fluid volume. For example, for blood oxygenation, this should enable the building of blood oxygenator cartridges that are more compact, have less pressure drop and cause less damage to red blood cells, all of which could lead to a reduction in post-surgical complications.”
About CVD Equipment Corporation
CVD Equipment Corporation (NASDAQ: CVV) designs, develops, and manufactures a broad range of chemical vapor deposition, gas control, and other state-of-the-art equipment and process solutions used to develop and manufacture materials and coatings for research and industrial applications. This equipment is used by its customers to research, design, and manufacture these materials or coatings for aerospace engine components, medical implants, semiconductors, solar cells, smart glass, carbon nanotubes, nanowires, LEDs, MEMS, and other applications. Through its application laboratory, the Company provides process development support and process startup assistance with the focus on enabling tomorrow’s technologies™. It’s wholly owned subsidiary CVD Materials Corporation provides advanced materials and metal surface treatments and coatings to serve demanding applications in the electronic, biomedical, petroleum, pharmaceutical, and many other industrial markets.
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by CVD Equipment Corporation) contains statements that are forward-looking. All statements other than statements of historical fact are hereby identified as “forward-looking statements, “as such term is defined in Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward looking information involves a number of known and unknown risks and uncertainties that could cause actual results to differ materially from those discussed or anticipated by management. Potential risks and uncertainties include, among other factors, conditions, success of CVD Equipment Corporation’s growth and sales strategies, the possibility of customer changes in delivery schedules, cancellation of orders, potential delays in product shipments, delays in obtaining inventory parts from suppliers and failure to satisfy customer acceptance requirements.
For further information about this topic please contact:
Phone: (631) 981-7081
Fax: (631) 981-7095
Email: firstname.lastname@example.org new email